Our data in six types of cancers showed overexpression of TMEFF2 in prostate tumors only, suggesting that this protein is not involved in tumorigenesis of highly aggressive cancers and that its expression could negatively control aggressiveness. Here, TMEFF2 is linked to prostate neoplasm.